环氧合酶-2及其选择性抑制剂在心血管疾病中的研究现状
Present status of research on cyclooxygenase-2(Cox-2) and it's selective inhibition in cardiovascular diseases
出处
《老年医学与保健》
CAS
2004年第4期250-252,共3页
Geriatrics & Health Care
参考文献20
-
1Cipollone F, Prontera C, Pini B, et al.Overexpression of functionally coupled cyclooxygenase- 2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)- dependent plaque instability.Circulation,2001,104(8): 921
-
2Altman R, Luciardi HL, Muntaner J, et al.Efficacy assessment of meloxicam,a preferential cyclooxygenase- 2 inhibitor,in acute coronary syndromes without ST- segment elevation: the Nonsteroidal Anti- Inflammatory Drugs in Unstable Angina Treatment- 2(NUT-
-
3Caughey GE, Cleland LG, Penglis PS, et al.Roles of cyclooxygenase(COX)- 1 and COX- 2 in prostanoid production by human endothelial cells: selective up- regulation of prostacyclin synthesis by COX- 2.J Immunol, 2001,167(5):2831～2838.
-
4Moulton KS, Heller E, Konerding MA, et al.Angiogenesis inhibitors endostatin or TNP- 470 reduce intimal neovascularization and plaque growth in apolipoprotein E- deficient mice.Circulation, 1999, 99(13):1726～1732.
-
5Belton O, Byrne D, Kearney D, et al.Cyclooxygenase- 1 and - 2- dependent prostacyclin formation in patients with atherosclerosis.Circulation,2000,102(8):840-845.
-
6Smith WL, Garavito RM, DeWitt DL.Prostaglandin endoperoxide H synthases(cyclooxygenases)- 1 and - 2.J Biol Chem, 1996, 271(52): 33157-33160.
-
7Barter P, Rye K.High density lipoproteins and coronary heart disease.Atherosclerosis,1996,121(1): 1-12.
-
8Vinals M, Martinez- Gonzalez J, Badimon JJ, et al.HDL- induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase- 2(Cox- 2).Arterioscler Thromb Vasc Biol, 1997, 17(12): 3481-3488.
-
9Loftus IM, Naylor AR, Goodall S, et al.Increased matrix metalloproteinase- 9 activity in unstable carotid plaques.A potential role in acute plaque disruption.Stroke,2000,31(1):40-47.
-
10Ahuja N, Singh A, Singh B.Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.J Pharm Pharmacol, 2003, 55(7): 859-894.
-
1美找到“饿死”肿瘤新方法[J].新华文摘,2009(21):145-145.
-
2童群.发放降糖药时应交代的事项[J].河北医药,2004,26(11):900-901. 被引量：2
-
3芦晓春,彭骥涛,宋岳.马来酸氯苯那敏片含量测定方法改进[J].中国药业,2009,18(4):30-30. 被引量：4
-
4余辉,梁水庭.影响肝癌根治术后复发的危险因素研究现状[J].中国医学文摘（肿瘤学）,2005,19(2):154-156.
-
5高峰.食管癌研究现状综述[J].蚌埠医学院学报,2010,35(6):645-648. 被引量：27
-
6陈晋,吴诚义.nm23基因及其在乳腺癌中的研究现状[J].医学综述,2002,8(8):437-438. 被引量：2
-
7胡兴国,王钧,曾因明,段世明,许鹏程.异丙酚对大鼠不同脑区NOS活性和NO产量的影响[J].中华麻醉学杂志,1998,18(7):427-428. 被引量：6
-
8李佳妮,王卓,孙瑞,杨勇.肿瘤相关巨噬细胞的研究进展和临床应用[J].药学研究,2016,35(4):237-239. 被引量：1
-
9Joann,G.,Elmore,Katrina,Armstrong,Constance,D.,Lehman,Suzanne,W.,Fletcher,王殊（译）,祝学光（校）.乳腺癌筛查[J].美国医学会杂志（中文版）,2006,25(2):97-106.
-
10左朝晖,谌忠友,莫胜川.环氧合酶-2与肝细胞癌的关系[J].中国肿瘤,2005,14(2):115-118. 被引量：1
